BRCA1 and breast cancer: Activation of this pathway not only results in increased proliferation of basal cells in mammary ductal epithelium, but also leads to mammary cancer predisposition in a rodent model [13,14,15], underscoring a potentially important cell-nonautonomous scenario contributing to breast cancer predisposition in BRCA1 mutation carriers.